Patient Assessment of Foam Attributes from the Tazarotene Foam, 0.1%, Phase III Trials and Potential Impact on Patient Compliance

Main Article Content

Rhonda Schreiber
Caitlin Lewis
Kaytiana Crane


tazarotene, acne


Abstract not available.


Disclosures: Study sponsored by Mayne Pharma.

Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 > >>